Free shipping on all orders over $ 500

RGX-104

Cat. No. M10589

All AbMole products are for research use only, cannot be used for human consumption.

RGX-104 Structure
Synonym:

SB 742881; RGX-104 free form

Size Price Availability Quantity
1mg USD 30 In stock
5mg USD 90 In stock
10mg USD 150 In stock
25mg USD 280 In stock
50mg USD 460 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

RGX-104, also known as SB 742881, is a liver X receptor beta (LXR) agonist with potential immunomodulating and antineoplastic activities. RGX-104 modulates innate immunity via transcriptional activation of the ApoE gene.

Oral administration of RGX-104 selectively targets and binds to LXRbeta, thereby activating LXRbeta-mediated signaling, leading to the transcription of certain tumor suppressor genes and the downregulation of certain tumor promoter genes. This particularly activates the expression of apolipoprotein E (ApoE), a tumor suppressor protein, in tumor cells and certain immune cells. This activates the innate immune system, resulting in depletion of immunosuppressive myeloid-derived suppressor cells (MDSCs), tumor cells and endothelial cells in the tumor microenvironment. This reverses immune evasion, enhances anti-tumor immune responses and inhibits proliferation of tumor cells.

Chemical Information
Molecular Weight 596.08
Formula C34H33ClF3NO3
CAS Number 610318-54-2
Solubility (25°C) DMSO 90 mg/mL
Storage 2-8°C, protect from light, sealed
References

[1] Masoud F Tavazoie, et al. Cell. LXR/ApoE Activation Restricts Innate Immune Suppression in Cancer

[2] Karpagam Aravindhan, et al. J Lipid Res. Assessing the effects of LXR agonists on cellular cholesterol handling: a stable isotope tracer study

Related Liver X Receptor Products
GW3965 hydrochloride

GW3965 hydrochloride is a selective, orally active non-steroidal synthetic liver X receptor (LXR) agonist.

T0901317

T0901317 is a potent and selective agonist for both LXRα and LXRβ with an EC50 of 20~50 nM. T0901317 activates FXR with an EC50 of 5 μM. T0901317 is RORα and RORγ dual inverse agonist with Ki values of 132 nM and 51 nM, respectively.

SR9243

SR9243 is a potent and selective LXR inverse agonist.

LXR-623

LXR-623 is a novel liver X-receptor(LXR) agonist with IC50 values of 179 nM and 24 nM for LXR-α and LXR-β, respectively. It is orally bioavailable and readily passes the blood-brain barrier.

GSK2033

GSK2033 is a potent LXR antagonist.

  Catalog
Abmole Inhibitor Catalog




Keywords: RGX-104, SB 742881; RGX-104 free form supplier, Liver X Receptor, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.